According to Zhitong Finance App News, Shiyao Group (01093) announced that the Group will present 8 latest clinical trial developments at the European Society of Medical Oncology (ESMO) annual meeting to be held in Madrid, Spain from October 23 to October 27, 2026, 2 of which were selected for the latest breakthrough abstract (LBA). The 8 clinical advances selected this time will be presented in the form of 1 selected oral report, 3 quick oral reports, 3 posters, and 1 electronic poster, covering breast cancer, lung cancer, stomach cancer, liver cancer, colon cancer, pancreatic cancer, perivascular epithelioma, etc., fully demonstrating the Group's R&D strength and clinical research capabilities in the field of tumor treatment.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.